Reprogramming of Cell Death Pathways by Bacterial Effectors as a Widespread Virulence Strategy

被引:18
作者
Wanford, Joseph J. [1 ]
Hachani, Abderrahman [2 ]
Odendall, Charlotte [1 ]
机构
[1] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England
[2] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
基金
英国医学研究理事会; 英国惠康基金;
关键词
apoptosis; immunity; infection; inflammasome; inflammation; necroptosis; programmed cell death; pyroptosis; T3SS; virulence; III SECRETION SYSTEM; ESCHERICHIA-COLI; INFLAMMASOME ACTIVATION; SHIGELLA-FLEXNERI; CYTOCHROME-C; FUNCTIONAL-ANALYSIS; PYRIN INFLAMMASOME; INDUCED APOPTOSIS; EPITHELIAL-CELLS; BAX INHIBITOR-1;
D O I
10.1128/iai.00614-21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The modulation of programmed cell death (PCD) processes during bacterial infections is an evolving arms race between pathogens and their hosts. The initiation of apoptosis, necroptosis, and pyroptosis pathways are essential to immunity against many intracellular and extracellular bacteria. These cellular self-destructive mechanisms are used by the infected host to restrict and eliminate bacterial pathogens. Without a tight regulatory control, host cell death can become a double-edged sword. Inflammatory PCDs contribute to an effective immune response against pathogens, but unregulated inflammation aggravates the damage caused by bacterial infections. Thus, fine-tuning of these pathways is required to resolve infection while preserving the host immune homeostasis. In turn, bacterial pathogens have evolved secreted virulence factors or effector proteins that manipulate PCD pathways to promote infection. In this review, we discuss the importance of controlled cell death in immunity to bacterial infection. We also detail the mechanisms employed by type 3 secreted bacterial effectors to bypass these pathways and their importance in bacterial pathogenesis.
引用
收藏
页数:17
相关论文
共 184 条
[1]   Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis [J].
Aili, M ;
Isaksson, EL ;
Hallberg, B ;
Wolf-Watz, H ;
Rosqvist, R .
CELLULAR MICROBIOLOGY, 2006, 8 (06) :1020-1033
[2]   Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century [J].
Anderson, Mark ;
Sansonetti, Philippe J. ;
Marteyn, Benoit S. .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2016, 6
[3]   A unique bacterial tactic to circumvent the cell death crosstalk induced by blockade of caspase-8 [J].
Ashida, Hiroshi ;
Sasakawa, Chihiro ;
Suzuki, Toshihiko .
EMBO JOURNAL, 2020, 39 (17)
[4]   The NAIP/NLRC4 inflammasome in infection and pathology [J].
Bauer, Renate ;
Rauch, Isabella .
MOLECULAR ASPECTS OF MEDICINE, 2020, 76
[5]   Emerging connectivity of programmed cell death pathways and its physiological implications [J].
Bedoui, Sammy ;
Herold, Marco J. ;
Strasser, Andreas .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (11) :678-695
[6]   Calpain Activation by the Shigella flexneri Effector VirA Regulates Key Steps in the Formation and Life of the Bacterium's Epithelial Niche [J].
Bergounioux, Jean ;
Elisee, Ruben ;
Prunier, Anne-Laure ;
Donnadieu, Francoise ;
Sperandio, Brice ;
Sansonetti, Philippe ;
Arbibe, Laurence .
CELL HOST & MICROBE, 2012, 11 (03) :240-252
[7]   Induction of Nonapoptotic Cell Death by Activated Ras Requires Inverse Regulation of Rac1 and Arf6 [J].
Bhanot, Haymanti ;
Young, Ashley M. ;
Overmeyer, Jean H. ;
Maltese, William A. .
MOLECULAR CANCER RESEARCH, 2010, 8 (10) :1358-1374
[8]   The Salmonella pathogenicity island-2 subverts human NLRP3 and NLRC4 inflammasome responses [J].
Bierschenk, Damien ;
Monteleone, Mercedes ;
Moghaddas, Fiona ;
Baker, Paul J. ;
Masters, Seth L. ;
Boucher, Dave ;
Schroder, Kate .
JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (02) :401-410
[9]   The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence [J].
Black, DS ;
Bliska, JB .
MOLECULAR MICROBIOLOGY, 2000, 37 (03) :515-527
[10]   The E. coli Effector Protein NleF Is a Caspase Inhibitor [J].
Blasche, Sonja ;
Moertl, Mario ;
Steuber, Holger ;
Siszler, Gabriella ;
Nisa, Shahista ;
Schwarz, Frank ;
Lavrik, Inna ;
Gronewold, Thomas M. A. ;
Maskos, Klaus ;
Donnenberg, Michael S. ;
Ullmann, Dirk ;
Uetz, Peter ;
Koegl, Manfred .
PLOS ONE, 2013, 8 (03)